Matches in SemOpenAlex for { <https://semopenalex.org/work/W2798231569> ?p ?o ?g. }
- W2798231569 abstract "Despite the significant upgrading in recent years of the role of 18F-FDG PET/CT in multiple myeloma (MM) diagnostics, there is a still unmet need for myeloma-specific radiotracers. 3'-Deoxy-3'-[18F]fluorothymidine (18F-FLT) is the most studied cellular proliferation PET agent, considered a potentially new myeloma functional imaging tracer. The aim of this pilot study was to evaluate 18F-FLT PET/CT in imaging of MM patients, in the context of its combined use with 18F-FDG PET/CT.Eight patients, four suffering from symptomatic MM and four suffering from smoldering MM (SMM), were enrolled in the study. All patients underwent 18F-FDG PET/CT and 18F-FLT PET/CT imaging by means of static (whole body) and dynamic PET/CT of the lower abdomen and pelvis (dPET/CT) in two consecutive days. The evaluation of PET/CT studies was based on qualitative evaluation, semi-quantitative (SUV) calculation, and quantitative analysis based on two-tissue compartment modeling. 18F-FDG PET/CT demonstrated focal, 18F-FDG avid, MM-indicative bone marrow lesions in five patients. In contrary, 18F-FLT PET/CT showed focal, 18F-FLT avid, myeloma-indicative lesions in only two patients. In total, 48 18F-FDG avid, focal, MM-indicative lesions were detected with 18F-FDG PET/CT, while 17 18F-FLT avid, focal, MM-indicative lesions were detected with 18F-FLT PET/CT. The number of myeloma-indicative lesions was significantly higher for 18F-FDG PET/CT than for 18F-FLT PET/CT. A common finding was a mismatch of focally increased 18F-FDG uptake and reduced 18F-FLT uptake (lower than the surrounding bone marrow). Moreover, 18F-FLT PET/CT was characterized by high background activity in the bone marrow compartment, further complicating the evaluation of bone marrow lesions. Semi-quantitative evaluation revealed that both SUVmean and SUVmax were significantly higher for 18F-FLT than for 18F-FDG in both MM lesions and reference tissue. SUV values were higher in MM lesions than in reference bone marrow for both tracers.Despite the limited number of patients analyzed in this pilot study, the first results of the trial indicate that 18F-FLT does not seem suitable as a single tracer in MM diagnostics. Further studies with a larger patient population are warranted to generalize the herein presented results." @default.
- W2798231569 created "2018-04-24" @default.
- W2798231569 creator A5008622761 @default.
- W2798231569 creator A5042184078 @default.
- W2798231569 creator A5044583234 @default.
- W2798231569 creator A5055916434 @default.
- W2798231569 creator A5075067956 @default.
- W2798231569 date "2018-04-10" @default.
- W2798231569 modified "2023-10-16" @default.
- W2798231569 title "Assessment of glucose metabolism and cellular proliferation in multiple myeloma: a first report on combined 18F-FDG and 18F-FLT PET/CT imaging" @default.
- W2798231569 cites W1580756501 @default.
- W2798231569 cites W1766290423 @default.
- W2798231569 cites W1833829642 @default.
- W2798231569 cites W1964985260 @default.
- W2798231569 cites W1966035337 @default.
- W2798231569 cites W1969552142 @default.
- W2798231569 cites W1969980764 @default.
- W2798231569 cites W1975304410 @default.
- W2798231569 cites W1981161460 @default.
- W2798231569 cites W1987934775 @default.
- W2798231569 cites W2001468757 @default.
- W2798231569 cites W2002033510 @default.
- W2798231569 cites W2004345432 @default.
- W2798231569 cites W2007074692 @default.
- W2798231569 cites W2044436186 @default.
- W2798231569 cites W2050654453 @default.
- W2798231569 cites W2073370692 @default.
- W2798231569 cites W2081608354 @default.
- W2798231569 cites W2097259163 @default.
- W2798231569 cites W2099276136 @default.
- W2798231569 cites W2103780528 @default.
- W2798231569 cites W2139119481 @default.
- W2798231569 cites W2139789239 @default.
- W2798231569 cites W2141014263 @default.
- W2798231569 cites W2152203157 @default.
- W2798231569 cites W2158515198 @default.
- W2798231569 cites W2175010453 @default.
- W2798231569 cites W2228023449 @default.
- W2798231569 cites W2263098589 @default.
- W2798231569 cites W2278848590 @default.
- W2798231569 cites W2292187888 @default.
- W2798231569 cites W2301015049 @default.
- W2798231569 cites W2397756846 @default.
- W2798231569 cites W2403428001 @default.
- W2798231569 cites W2525852273 @default.
- W2798231569 cites W2564210624 @default.
- W2798231569 cites W2601172279 @default.
- W2798231569 cites W2607239695 @default.
- W2798231569 cites W2620785926 @default.
- W2798231569 cites W2733117179 @default.
- W2798231569 doi "https://doi.org/10.1186/s13550-018-0383-7" @default.
- W2798231569 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5891438" @default.
- W2798231569 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29633046" @default.
- W2798231569 hasPublicationYear "2018" @default.
- W2798231569 type Work @default.
- W2798231569 sameAs 2798231569 @default.
- W2798231569 citedByCount "15" @default.
- W2798231569 countsByYear W27982315692019 @default.
- W2798231569 countsByYear W27982315692021 @default.
- W2798231569 countsByYear W27982315692022 @default.
- W2798231569 countsByYear W27982315692023 @default.
- W2798231569 crossrefType "journal-article" @default.
- W2798231569 hasAuthorship W2798231569A5008622761 @default.
- W2798231569 hasAuthorship W2798231569A5042184078 @default.
- W2798231569 hasAuthorship W2798231569A5044583234 @default.
- W2798231569 hasAuthorship W2798231569A5055916434 @default.
- W2798231569 hasAuthorship W2798231569A5075067956 @default.
- W2798231569 hasBestOaLocation W27982315691 @default.
- W2798231569 hasConcept C126322002 @default.
- W2798231569 hasConcept C126838900 @default.
- W2798231569 hasConcept C127077266 @default.
- W2798231569 hasConcept C151730666 @default.
- W2798231569 hasConcept C2775842073 @default.
- W2798231569 hasConcept C2776364478 @default.
- W2798231569 hasConcept C2779343474 @default.
- W2798231569 hasConcept C2989005 @default.
- W2798231569 hasConcept C71924100 @default.
- W2798231569 hasConcept C86803240 @default.
- W2798231569 hasConceptScore W2798231569C126322002 @default.
- W2798231569 hasConceptScore W2798231569C126838900 @default.
- W2798231569 hasConceptScore W2798231569C127077266 @default.
- W2798231569 hasConceptScore W2798231569C151730666 @default.
- W2798231569 hasConceptScore W2798231569C2775842073 @default.
- W2798231569 hasConceptScore W2798231569C2776364478 @default.
- W2798231569 hasConceptScore W2798231569C2779343474 @default.
- W2798231569 hasConceptScore W2798231569C2989005 @default.
- W2798231569 hasConceptScore W2798231569C71924100 @default.
- W2798231569 hasConceptScore W2798231569C86803240 @default.
- W2798231569 hasFunder F4320320879 @default.
- W2798231569 hasIssue "1" @default.
- W2798231569 hasLocation W27982315691 @default.
- W2798231569 hasLocation W27982315692 @default.
- W2798231569 hasLocation W27982315693 @default.
- W2798231569 hasLocation W27982315694 @default.
- W2798231569 hasLocation W27982315695 @default.
- W2798231569 hasOpenAccess W2798231569 @default.
- W2798231569 hasPrimaryLocation W27982315691 @default.
- W2798231569 hasRelatedWork W1997103520 @default.
- W2798231569 hasRelatedWork W2021729604 @default.
- W2798231569 hasRelatedWork W2029854421 @default.